Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/62671
Citations
Scopus Web of ScienceĀ® Altmetric
?
?
Type: Journal article
Title: Harnessing the complexity of DNA-damage response pathways to improve cancer treatment outcomes
Author: Al-ejeh, F.
Sharma, R.
Wiegmans, A.
Lakhani, S.
Brown, M.
Khanna, K.
Citation: Oncogene, 2010; 29(46):6085-6098
Publisher: Nature Publishing Group
Issue Date: 2010
ISSN: 0950-9232
1476-5594
Statement of
Responsibility: 
F. Al-Ejeh, R. Kumar, A. Wiegmans, S. R. Lakhani, M. P. Brown and K. K. Khanna
Abstract: The DNA-damage response (DDR) pathways consist of interconnected components that respond to DNA damage to allow repair and promote cell survival. The DNA repair pathways and downstream cellular responses have diverged in cancer cells compared with normal cells because of genetic alterations that underlie drug resistance, disabled repair and resistance to apoptosis. Consequently, abrogating DDR pathways represents an important mechanism for enhancing the therapeutic index of DNA-damaging anticancer agents. In this review, we discuss the DDR pathways that determine antitumor effects of DNA-damaging agents with a specific focus on treatment outcomes in tumors carrying a defective p53 pathway. Finely tuned survival and death pathways govern the cellular responses downstream of the cytotoxic insults inherent in anticancer treatment. The significance and relative contributions of cellular responses including apoptosis, mitotic catastrophe and senescence are discussed in relation to the web of molecular interactions that affect such outcomes. We propose that promising combinations of DNA-damaging anticancer treatments with DDR-pathway inhibition would be further enhanced by activating downstream apoptotic pathways. The proposed rationale ensures that actual cell death is the preferred outcome of cancer treatment instead of other responses, including reversible cell cycle arrest, autophagy or senescence. Finally, to better measure the contribution of different cellular responses to anticancer treatments, multiplex in vivo assessments of therapy-induced response pathways such as cell death, senescence and mitotic catastrophe is desirable rather than the current reliance on the measurement of a single response pathway such as apoptosis.
Keywords: DNA-damage response; DNA repair; cell cycle checkpoints; cell death; mitotic catastrophe; cellular senescence
Rights: Copyright 2010 Macmillan Publishers Limited
RMID: 0020101558
DOI: 10.1038/onc.2010.407
Grant ID: http://purl.org/au-research/grants/arc/DP0880372
http://purl.org/au-research/grants/nhmrc/442903
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.